Previous 10 | Next 10 |
SAN CLEMENTE, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2023 earnings release and conference call. The Company will release its f...
2023-03-29 10:11:31 ET ICU Medical ( ICUI ) is joining with a private equity firm to compete with GE Healthcare ( GEHC ) as the companies try to acquire two medical technology units that Medtronic ( NYSE: MDT ) is selling. ICU Medical gained 2.3%. Medtronic is ...
2023-03-24 13:12:12 ET The following slide deck was published by ICU Medical, Inc. in conjunction with this event. For further details see: ICU Medical (ICUI) presents at Raymond James Institutional Investors Conference - Slideshow
SAN CLEMENTE, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTec...
Summary Atrion Corporation has done well from a sales perspective very recently, but its overall financial performance in recent years has been disappointing. This is especially true of bottom line results that have shown no real growth. The firm is a stable operator that should be ...
Summary ICU Medical spent far more time, energy, and resources than expected in 2022 on fixing Smiths Medical, but the heavy lifting seems largely done for most of the businesses. Allowing that current results don't reflect the full impact of the improvements management has made, underl...
ICU Medical, Inc. (ICUI) Q4 2022 Earnings Conference Call February 27, 2023 16:30 ET Company Participants John Mills - ICR Vivek Jain - Chairman & Chief Executive Officer Brian Bonnell - Chief Financial Officer & Treasurer Conference Call Participants ...
ICU Medical press release ( NASDAQ: ICUI ): Q4 Non-GAAP EPS of $1.60 beats by $0.04 . Revenue of $578.01M (+69.7% Y/Y) misses by $4.92M . 2023 Guidance: For Fiscal Year 2023 the Company estimates GAAP net loss to be in the range of $(73) to $(37) and GAAP diluted l...
SAN CLEMENTE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2022. Fourth Quarter 2022 Results Fourth qu...
SAN CLEMENTE, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 44 th Annual Institutional Investors Conference ...
News, Short Squeeze, Breakout and More Instantly...
SAN CLEMENTE, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2024 earnings release and conference call. The Company will release its ...
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. First Quarter 2024 Results First...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...